Most viruses, including SARs-COV-2, enter the body through the mucosa and infect the cells in the mucosal membranes. Thus nasal vaccines administered inside the nose are considered effective. Hyderabad-based Bharat Biotech is developing BBV154, an intranasal Covid-19 vaccine. Watch the video to know more.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting